Nabitan    B-Acetylene114600742

The    O
octynes    B-Acetylene114600742
are    O
a    O
subgroup    O
from    O
the    O
group    O
of    O
alkynes    O
.    O

Cellocidin    B-Acetylene114600742
(    O
2-butynediamide    O
)    O
is    O
an    O
organic    O
chemical    O
compound    O
with    O
the    O
molecular    O
formula    O
C4H4O2N2    O
.    O

ICI-190,622    B-Acetylene114600742

The    O
propargyl    O
ether    O
is    O
called    O
Pargolol    B-Acetylene114600742
.    O

JNJ-7925476    B-Acetylene114600742

Linear    B-Acetylene114600742
acetylenic    I-Acetylene114600742
carbon    I-Acetylene114600742
,    O
a    O
polymeric    O
carbon    O
chain    O

Linear    B-Acetylene114600742
acetylenic    I-Acetylene114600742
carbon    I-Acetylene114600742
(    O
Carbyne    O
)    O

1-Chloro-9,10-bis(phenylethynyl)anthracene    B-Acetylene114600742
is    O
a    O
fluorescent    O
dye    O
used    O
in    O
lightsticks    O
.    O

Vinylacetylene    B-Acetylene114600742
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
C4H4    O
.    O

Its    O
most    O
singular    O
hazard    O
is    O
associated    O
with    O
its    O
intrinsic    O
instability    O
,    O
especially    O
when    O
it    O
is    O
pressurized    O
:    O
under    O
certain    O
conditions    O
acetylene    O
can    O
react    O
in    O
an    O
exothermic    O
addition    O
-    O
type    O
reaction    O
to    O
form    O
a    O
number    O
of    O
products    O
,    O
typically    O
benzene    O
and/or    O
vinylacetylene    B-Acetylene114600742
,    O
possibly    O
in    O
addition    O
to    O
carbon    O
and    O
hydrogen    O
.    O

With    O
simple    O
hydrocarbons    O
,    O
this    O
usage    O
is    O
identical    O
to    O
the    O
IUPAC    O
suffix    O
-yne    B-Acetylene114600742
.    O

O-823    B-Acetylene114600742
is    O
a    O
drug    O
which    O
is    O
a    O
cannabinoid    O
derivative    O
that    O
is    O
used    O
in    O
scientific    O
research    O
.    O

It    O
can    O
also    O
be    O
reacted    O
with    O
sulfur    O
tetrafluoride    O
to    O
produce    O
hexafluoro-2-butyne    B-Acetylene114600742
,    O
a    O
powerful    O
dienophile    O
for    O
use    O
in    O
Diels    O
-    O
Alder    O
reactions    O
.    O

3-Hexyne    B-Acetylene114600742
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
C2H5CCC2H5    O
,    O
simplified    O
to    O
C6H10    O
.    O

As    O
with    O
dynemicin    O
A    O
,    O
neocarzinostatin    B-Acetylene114600742
also    O
interacts    O
with    O
DNA    O
.    O

A-40174    B-Acetylene114600742

Antagonists    O
/    O
negative    O
allosteric    O
modulators    O
:    O
bicuculline    O
,    O
cicutoxin    B-Acetylene114600742
,    O
flumazenil    O
,    O
furosemide    O
,    O
gabazine    O
,    O
oenanthotoxin    B-Acetylene114600742
,    O
picrotoxin    O
,    O
Ro15    O
-    O
4513    O
,    O
thujone    O
,    O
amentoflavone    O
.    O

The    O
chief    O
poison    O
is    O
cicutoxin    B-Acetylene114600742
,    O
an    O
unsaturated    O
aliphatic    O
alcohol    O
that    O
is    O
most    O
concentrated    O
in    O
the    O
roots    O
.    O

Propiolic    B-Acetylene114600742
acid    I-Acetylene114600742
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
HC2CO2H.    O
It    O
is    O
the    O
simplest    O
acetylenic    O
carboxylic    O
acid    O
.    O

Iodopropynyl    B-Acetylene114600742
butylcarbamate    I-Acetylene114600742
is    O
a    O
wood    O
and    O
paint    O
preservative    O
and    O
used    O
in    O
cosmetics    O
.    O

Norsteroid    O
examples    O
include    O
:    O
19-norpregnane    O
(    O
from    O
pregnane    O
)    O
,    O
desogestrel    B-Acetylene114600742
,    O
ethylestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
ethinylestradiol    O
,    O
gestrinone    B-Acetylene114600742
,    O
levonorgestrel    B-Acetylene114600742
,    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norgestrel    O
,    O
norpregnatriene    O
(    O
from    O
pregnatriene    O
)    O
,    O
quinestrol    O
,    O
19-norprogesterone    O
(    O
from    O
a    O
progesterone    O
)    O
,    O
Nomegestrol    O
acetate    O
,    O
19-nortestosterone    O
(    O
from    O
a    O
testosterone    O
)    O
,    O
and    O
norethisterone    O
acetate    O
.    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

A    O
2001    O
comparative    O
study    O
of    O
the    O
IMS    O
LifeLink    O
Health    O
Plan    O
Claims    O
Database    O
interpreted    O
that    O
in    O
a    O
large    O
cohort    O
of    O
women    O
using    O
oral    O
contraceptives    O
,    O
there    O
was    O
found    O
a    O
small    O
,    O
statistically    O
significant    O
increase    O
in    O
the    O
risk    O
of    O
gallbladder    O
disease    O
associated    O
with    O
desogestrel    B-Acetylene114600742
,    O
drospirenone    O
and    O
norethisterone    B-Acetylene114600742
compared    O
with    O
levonorgestrel    B-Acetylene114600742
.    O

It    O
is    O
an    O
isomer    O
of    O
2-pentyne    B-Acetylene114600742
,    O
an    O
internal    O
alkyne    O
.    O

Overman    O
has    O
also    O
worked    O
extensively    O
on    O
the    O
aza    O
-    O
Cope    O
-    O
Mannich    O
reaction    O
,    O
originally    O
designed    O
to    O
solve    O
a    O
stereoelectronic    O
problem    O
in    O
the    O
total    O
synthesis    O
of    O
gephyrotoxin    B-Acetylene114600742
.    O

There    O
is    O
little    O
experimental    O
evidence    O
supporting    O
the    O
existence    O
of    O
cyclobutyne    B-Acetylene114600742
(    O
C4H4    O
)    O
or    O
cyclopropyne    O
(    O
C3H2    O
)    O
,    O
aside    O
from    O
studies    O
reporting    O
the    O
isolation    O
of    O
an    O
osmium    O
complex    O
with    O
cyclobutyne    O
ligands    O
.    O

The    O
term    O
ozogamicin    O
in    O
the    O
names    O
of    O
monoclonal    O
antibodies    O
or    O
antibody    O
-    O
drug    O
conjugates    O
indicates    O
that    O
they    O
are    O
linked    O
to    O
a    O
cytotoxic    O
agent    O
from    O
the    O
class    O
of    O
calicheamicin    B-Acetylene114600742
,    O
as    O
in    O
:    O

The    O
calicheamicins    B-Acetylene114600742
are    O
a    O
class    O
of    O
enediyne    B-Acetylene114600742
antitumor    O
antibiotics    O
derived    O
from    O
the    O
bacterium    O
"    O
Micromonospora    O
echinospora    O
"    O
,    O
with    O
calicheamicin    O
γ1    O
being    O
the    O
most    O
notable    O
.    O

Among    O
the    O
molecules    O
synthesized    O
by    O
Danishefsky    O
at    O
Columbia    O
University    O
are    O
epothilones    O
and    O
calicheamicin    B-Acetylene114600742
,    O
which    O
are    O
natural    O
products    O
with    O
promise    O
as    O
anti    O
-    O
cancer    O
agents    O
.    O

Propargyl    B-Acetylene114600742
chloride    I-Acetylene114600742

ABT-239    O
is    O
more    O
active    O
at    O
the    O
human    O
H3    O
receptor    O
than    O
comparable    O
agents    O
such    O
as    O
thioperamide    O
,    O
ciproxifan    O
,    O
and    O
cipralisant    B-Acetylene114600742
.    O

9,10-bis(phenylethynyl)anthracene    B-Acetylene114600742

1-Butyne    B-Acetylene114600742
(    O
ethylacetylene    O
)    O

Beraprost    B-Acetylene114600742
is    O
a    O
pharmaceutical    O
drug    O
used    O
in    O
several    O
Asian    O
countries    O
,    O
including    O
Japan    O
and    O
South    O
Korea    O
,    O
as    O
a    O
vasodilator    O
and    O
antiplatelet    O
agent    O
.    O

Clorgiline    B-Acetylene114600742
(    O
INN    O
)    O
,    O
or    O
clorgyline    B-Acetylene114600742
(    O
BAN    O
)    O
,    O
is    O
a    O
monoamine    O
oxidase    O
inhibitor    O
(    O
MAOI    O
)    O
structurally    O
related    O
to    O
pargyline    B-Acetylene114600742
which    O
is    O
described    O
as    O
an    O
antidepressant    O
.    O

This    O
detail    O
is    O
borrowed    O
from    O
pargyline    B-Acetylene114600742
,    O
an    O
older    O
phenethylamine    O
MAO    O
-    O
B    O
inhibitor    O
.    O

Empenthrin    B-Acetylene114600742
(    O
also    O
called    O
vaporthrin    B-Acetylene114600742
)    O
is    O
a    O
synthetic    O
pyrethroid    O
used    O
in    O
insecticides    O
.    O

Antrocamphin    B-Acetylene114600742
B    I-Acetylene114600742
is    O
a    O
bioactive    O
isolate    O
of    O
"    O
Taiwanofungus    O
camphoratus    O
"    O
.    O

pinazepam    B-Acetylene114600742

Graphyne    B-Acetylene114600742

The    O
Diels    O
–    O
Reese    O
Reaction    O
is    O
a    O
reaction    O
between    O
hydrazobenzene    O
and    O
dimethyl    B-Acetylene114600742
acetylenedicarboxylate    I-Acetylene114600742
(    O
or    O
related    O
esters    O
)    O
first    O
reported    O
in    O
1934    O
by    O
Otto    O
Diels    O
and    O
Johannes    O
Reese    O
.    O

For    O
example    O
,    O
an    O
analog    O
for    O
the    O
Diels    O
-    O
Alder    O
reaction    O
is    O
the    O
quadricyclane    O
-    O
DMAD    B-Acetylene114600742
reaction    O
:    O

Falcarinol    B-Acetylene114600742

Ivy    O
foliage    O
contains    O
triterpenoid    O
saponins    O
and    O
falcarinol    B-Acetylene114600742
.    O

PARGY-LAD    B-Acetylene114600742
is    O
an    O
analogue    O
of    O
LSD    O
.    O

Although    O
impractical    O
,    O
it    O
could    O
be    O
prepared    O
by    O
trimerization    O
of    O
propyne    B-Acetylene114600742
,    O
also    O
requiring    O
an    O
acid    O
catalyst    O
,    O
affords    O
a    O
mixture    O
of    O
1,3,5-    O
and    O
1,2,4-trimethylbenzenes    O
.    O

:    O
Prolate    O
:    O
chloromethane    O
,    O
,    O
propyne,    B-Acetylene114600742

It    O
is    O
a    O
halogenated    O
organic    O
compound    O
consisting    O
of    O
propyne    B-Acetylene114600742
with    O
a    O
bromine    O
substituent    O
on    O
the    O
methyl    O
group    O
.    O

dimethisterone    B-Acetylene114600742
(    O
INN    O
)    O

Similarly    O
to    O
extension    O
of    O
the    O
C17α    O
alkyl    O
chain    O
,    O
extension    O
of    O
the    O
C17α    O
ethynyl    O
chain    O
abolishes    O
androgenic    O
activity    O
,    O
as    O
with    O
dimethisterone    B-Acetylene114600742
(    O
6α,21-dimethylethisterone    O
)    O
.    O

moxestrol    B-Acetylene114600742
(    O
INN    O
)    O

Moxestrol    B-Acetylene114600742

O-806    B-Acetylene114600742
is    O
a    O
drug    O
which    O
is    O
a    O
cannabinoid    O
derivative    O
that    O
is    O
used    O
in    O
scientific    O
research    O
.    O

Other    O
molecules    O
detected    O
via    O
microwave    O
spectroscopy    O
include    O
cyanoacetylene    B-Acetylene114600742
,    O
cyclopropenylidene    O
,    O
methanol    O
,    O
silicon    O
monoxide    O
,    O
sulfur    O
monoxide    O
,    O
carbon    O
monosulfide    O
,    O
Thioformaldehyde    O
,    O
Hydrogen    O
isocyanide    O
,    O
Formamide    O
,    O
and    O
ions    O
H2N+    O
and    O
HCO+    O
.    O

Also    O
,    O
the    O
pure    O
rotational    O
spectra    O
of    O
HCCCN    B-Acetylene114600742
and    O
HCN    O
in    O
helium    O
were    O
observed    O
[    O
13    O
]    O
.    O

Combinations    O
containing    O
third-    O
or    O
fourth    O
-    O
generation    O
progestins    O
such    O
as    O
desogestrel    B-Acetylene114600742
,    O
drospirenone    O
,    O
or    O
norgestimate    B-Acetylene114600742
are    O
preferred    O
for    O
women    O
with    O
acne    O
due    O
to    O
their    O
stronger    O
antiandrogenic    O
effects    O
.    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

No    O
statistically    O
significant    O
increase    O
in    O
risk    O
was    O
associated    O
with    O
the    O
other    O
formulations    O
of    O
oral    O
contraceptive    O
(    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
norgestrel    O
and    O
norgestimate    B-Acetylene114600742
)    O
.    O

Quingestanol    B-Acetylene114600742
acetate    I-Acetylene114600742

Progestogen    O
esters    O
of    O
other    O
groups    O
of    O
progestins    O
have    O
also    O
been    O
introduced    O
,    O
including    O
the    O
19-norprogesterone    O
derivatives    O
gestonorone    O
caproate    O
,    O
segesterone    O
acetate    O
(    O
nestorone    O
)    O
,    O
nomegestrol    O
acetate    O
,    O
and    O
norgestomet    O
(    O
11β-methyl-17α-acetoxy-19-norprogesterone    O
)    O
,    O
and    O
the    O
19-nortestosterone    O
derivatives    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
and    O
quingestanol    B-Acetylene114600742
acetate    I-Acetylene114600742
.    O

Etynodiol    B-Acetylene114600742

etynodiol    B-Acetylene114600742
(    O
INN    O
)    O

It    O
is    O
a    O
prodrug    O
of    O
norethisterone    B-Acetylene114600742
,    O
with    O
both    O
quingestanol    B-Acetylene114600742
and    O
norethisterone    O
acetate    O
serving    O
as    O
intermediates    O
in    O
the    O
transformation    O
.    O

Such    O
process    O
often    O
involve    O
metal    O
acetylide    B-Acetylene114600742
intermediates    O

These    O
reactions    O
invariably    O
involve    O
metal    O
-    O
acetylide    B-Acetylene114600742
intermediates    O
.    O

Acetylide    B-Acetylene114600742
-    O
a    O
related    O
chemical    O
with    O
the    O
formula    O
C22−    O

Since    O
acetylene    O
has    O
a    O
pKa    O
of    O
25    O
,    O
acetylene    O
can    O
be    O
deprotonated    O
by    O
a    O
superbase    O
to    O
form    O
an    O
acetylide    B-Acetylene114600742
:    O

Copper    O
salts    O
react    O
with    O
terminal    O
alkynes    O
to    O
form    O
the    O
acetylide    B-Acetylene114600742
.    O

Oxidative    O
coupling    O
is    O
the    O
coupling    O
of    O
copper    O
acetylides    B-Acetylene114600742
to    O
conjugated    O
alkynes    O
in    O
the    O
Glaser    O
coupling    O
(    O
for    O
example    O
in    O
the    O
synthesis    O
of    O
cyclooctadecanonaene    O
)    O
or    O
to    O
aryl    O
halides    O
in    O
the    O
Castro    O
-    O
Stephens    O
Coupling    O
.    O

Acetylenedicarboxylic    B-Acetylene114600742
acid    I-Acetylene114600742

Other    O
more    O
exotic    O
carbon    O
–    O
oxygen    O
anions    O
exist    O
,    O
such    O
as    O
acetylenedicarboxylate    B-Acetylene114600742
(    O
O2C    O
–    O
C≡C    O
–    O
CO22−    O
)    O
,    O
mellitate    O
(    O
C12O96−    O
)    O
,    O
squarate    O
(    O
C4O42−    O
)    O
,    O
and    O
rhodizonate    O
(    O
C6O62−    O
)    O
.    O

Sodium    O
amide    O
induces    O
the    O
loss    O
of    O
two    O
equivalents    O
of    O
hydrogen    O
bromide    O
from    O
a    O
vicinal    O
dibromoalkane    O
to    O
give    O
a    O
carbon    O
-    O
carbon    O
triple    O
bond    O
,    O
as    O
in    O
a    O
preparation    O
of    O
phenylacetylene    B-Acetylene114600742
.    O

Reaction    O
of    O
this    O
compound    O
with    O
phenylacetylene    B-Acetylene114600742
produced    O
a    O
1,2    O
disilabenzene    O
.    O

This    O
reaction    O
was    O
discovered    O
by    O
chemist    O
John    O
Ulric    O
Nef    O
in    O
1899    O
while    O
experimenting    O
with    O
reactions    O
of    O
elemental    O
sodium    O
,    O
phenylacetylene    B-Acetylene114600742
,    O
and    O
acetophenone    O
.    O

Oxybutynin    B-Acetylene114600742
chloride    I-Acetylene114600742
–    O
an    O
involuntary    O
muscle    O
relaxant    O
and    O
spasmolytic    O
agent    O
,    O
used    O
to    O
reduce    O
spasticity    O
of    O
the    O
bladder    O
in    O
patients    O
with    O
bladder    O
control    O
problems    O

If    O
a    O
young    O
person    O
experiences    O
incontinence    O
resulting    O
from    O
an    O
overactive    O
bladder    O
,    O
a    O
doctor    O
might    O
prescribe    O
a    O
medicine    O
that    O
helps    O
to    O
calm    O
the    O
bladder    O
muscle    O
,    O
such    O
as    O
oxybutynin    B-Acetylene114600742
.    O

Other    O
agents    O
used    O
for    O
bladder    O
instillations    O
to    O
treat    O
interstitial    O
cystitis    O
include    O
:    O
heparin    O
,    O
lidocaine    O
,    O
chondroitin    O
sulfate    O
,    O
hyaluronic    O
acid    O
,    O
pentosan    O
polysulfate    O
,    O
oxybutynin    B-Acetylene114600742
,    O
and    O
botulinum    O
toxin    O
A.    O
Preliminary    O
evidence    O
suggests    O
these    O
agents    O
are    O
efficacious    O
in    O
reducing    O
symptoms    O
of    O
interstitial    O
cystitis    O
,    O
but    O
further    O
study    O
with    O
larger    O
,    O
randomized    O
,    O
controlled    O
clinical    O
trials    O
is    O
needed    O
.    O

Oxybutynin    B-Acetylene114600742
(    O
Ditropan    O
,    O
Driptane    O
,    O
Lyrinel    O
XL    O
)    O

Prallethrin    B-Acetylene114600742

Propargyl    B-Acetylene114600742
bromide    I-Acetylene114600742
,    O
also    O
known    O
as    O
3-bromo-1-propyne    B-Acetylene114600742
,    O
is    O
an    O
organic    O
compound    O
with    O
the    O
chemical    O
formula    O
CHCCH2Br    O
.    O

Another    O
possible    O
pathway    O
is    O
through    O
the    O
reaction    O
of    O
propynylidyne    B-Acetylene114600742
(    O
C3H    O
)    O
with    O
water    O
.    O

Norelgestromin    B-Acetylene114600742

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

Norsteroid    O
examples    O
include    O
:    O
19-norpregnane    O
(    O
from    O
pregnane    O
)    O
,    O
desogestrel    B-Acetylene114600742
,    O
ethylestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
ethinylestradiol    O
,    O
gestrinone    B-Acetylene114600742
,    O
levonorgestrel    B-Acetylene114600742
,    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norgestrel    O
,    O
norpregnatriene    O
(    O
from    O
pregnatriene    O
)    O
,    O
quinestrol    O
,    O
19-norprogesterone    O
(    O
from    O
a    O
progesterone    O
)    O
,    O
Nomegestrol    O
acetate    O
,    O
19-nortestosterone    O
(    O
from    O
a    O
testosterone    O
)    O
,    O
and    O
norethisterone    O
acetate    O
.    O

The    O
company    O
's    O
products    O
include    O
Botox    O
,    O
Namenda    O
,    O
Restasis    O
,    O
Linzess    O
,    O
Bystolic    O
,    O
Juvederm    O
,    O
Latisse    O
,    O
Lo    O
Loestrin    O
Fe    O
,    O
Estrace    O
,    O
Teflaro    O
,    O
Dalvance    O
,    O
Ozurdex    O
,    O
Optive    O
,    O
Natrelle    O
,    O
Viibryd    O
,    O
Liletta    B-Acetylene114600742
,    O
Saphris    O
,    O
Enablex    O
,    O
Actonel    O
,    O
Androderm    O
,    O
Gelnique    B-Acetylene114600742
and    O
others    O
.    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

The    O
Yuzpe    O
Regimen    O
is    O
a    O
method    O
of    O
emergency    O
contraception    O
using    O
a    O
combination    O
of    O
estrogen    O
and    O
progestogen    O
hormones    O
(    O
100    O
μg    O
ethinylestradiol    O
and    O
0.5    O
mg    O
of    O
levonorgestrel    B-Acetylene114600742
as    O
soon    O
as    O
possible    O
and    O
again    O
in    O
12    O
hrs    O
)    O
and    O
started    O
within    O
72    O
hours    O
of    O
sexual    O
intercourse    O
.    O

In    O
April    O
2005    O
,    O
Governor    O
Rod    O
Blagojevich    O
by    O
emergency    O
executive    O
order    O
required    O
all    O
pharmacists    O
to    O
provide    O
Plan    O
B    O
levonorgestrel    B-Acetylene114600742
.    O

Other    O
-    O
hemodialysis    O
,    O
excessive    O
UV    O
-    O
A    O
,    O
cola    O
,    O
oral    O
contraceptive    O
pills    O
(    O
levonorgestrel    B-Acetylene114600742
and    O
ethinylestradiol    O
)    O
,    O
narrowband    O
UV    O
-    O
B    O
phototherapy    O
(    O
rarely    O
)    O

Levonorgestrel    O
-    O
releasing    O
implant    O
,    O
sold    O
under    O
the    O
brand    O
name    O
Jadelle    O
among    O
others    O
,    O
is    O
a    O
device    O
made    O
up    O
of    O
a    O
two    O
rods    O
of    O
levonorgestrel    B-Acetylene114600742
used    O
for    O
birth    O
control    O
.    O

The    O
original    O
Norplant    O
consisted    O
of    O
a    O
set    O
of    O
six    O
small    O
(    O
2.4    O
mm    O
×    O
34    O
mm    O
)    O
silicone    O
capsules    O
,    O
each    O
filled    O
with    O
36    O
mg    O
of    O
levonorgestrel    B-Acetylene114600742
implanted    O
under    O
the    O
skin    O
in    O
the    O
upper    O
arm    O
and    O
effective    O
for    O
five    O
years    O
.    O

It    O
has    O
been    O
shown    O
to    O
prevent    O
about    O
62–85%    O
of    O
expected    O
pregnancies    O
,    O
and    O
prevents    O
more    O
pregnancies    O
than    O
emergency    O
contraception    O
with    O
levonorgestrel    B-Acetylene114600742
.    O

It    O
might    O
also    O
interact    O
with    O
hormonal    O
contraceptives    O
and    O
progestogens    O
such    O
as    O
levonorgestrel    B-Acetylene114600742
and    O
other    O
substrates    O
of    O
the    O
progesterone    O
receptor    O
,    O
as    O
well    O
as    O
with    O
glucocorticoids    O
.    O

Ethinylestradiol    O
/    O
levonorgestrel    O
(    O
also    O
ethinyl    O
estradiol    O
/    O
levonorgestrel    O
)    O
is    O
a    O
combined    O
birth    O
control    O
pill    O
made    O
up    O
of    O
ethinylestradiol    O
,    O
an    O
estrogen    O
and    O
levonorgestrel    B-Acetylene114600742
a    O
progestin    O
.    O

A    O
2001    O
comparative    O
study    O
of    O
the    O
IMS    O
LifeLink    O
Health    O
Plan    O
Claims    O
Database    O
interpreted    O
that    O
in    O
a    O
large    O
cohort    O
of    O
women    O
using    O
oral    O
contraceptives    O
,    O
there    O
was    O
found    O
a    O
small    O
,    O
statistically    O
significant    O
increase    O
in    O
the    O
risk    O
of    O
gallbladder    O
disease    O
associated    O
with    O
desogestrel    B-Acetylene114600742
,    O
drospirenone    O
and    O
norethisterone    B-Acetylene114600742
compared    O
with    O
levonorgestrel    B-Acetylene114600742
.    O

In    O
early    O
February    O
2006    O
,    O
Stephens    O
challenged    O
Blagojevich    O
in    O
an    O
appearance    O
on    O
"    O
The    O
Daily    O
Show    O
"    O
to    O
discuss    O
the    O
Governor    O
's    O
executive    O
order    O
that    O
pharmacists    O
must    O
dispense    O
any    O
drugs    O
for    O
which    O
a    O
customer    O
had    O
a    O
valid    O
prescription    O
,    O
including    O
birth    O
control    O
pills    O
and    O
Plan    B-Acetylene114600742
B    I-Acetylene114600742
Blagojevich    O
was    O
interviewed    O
by    O
Jason    O
Jones    O
,    O
who    O
repeatedly    O
pretended    O
to    O
be    O
unable    O
to    O
pronounce    O
Blagojevich    O
and    O
simply    O
called    O
him    O
"    O
Governor    O
Smith    O
"    O
.    O

GRN-529    B-Acetylene114600742

Oenanthotoxin    B-Acetylene114600742

Antagonists    O
/    O
negative    O
allosteric    O
modulators    O
:    O
bicuculline    O
,    O
cicutoxin    B-Acetylene114600742
,    O
flumazenil    O
,    O
furosemide    O
,    O
gabazine    O
,    O
oenanthotoxin    B-Acetylene114600742
,    O
picrotoxin    O
,    O
Ro15    O
-    O
4513    O
,    O
thujone    O
,    O
amentoflavone    O
.    O

SH-053-R-CH3-2′F    B-Acetylene114600742
is    O
a    O
drug    O
used    O
in    O
scientific    O
research    O
which    O
is    O
a    O
benzodiazepine    O
derivative    O
.    O

Imiprothrin    B-Acetylene114600742
is    O
a    O
synthetic    O
pyrethroid    O
insecticide    O
.    O

MPEP    B-Acetylene114600742

MPEP    B-Acetylene114600742

Micronor    B-Acetylene114600742

:    O
norethisterone    B-Acetylene114600742
(    O
contraceptive    O
)    O

In    O
contrast    O
,    O
the    O
non    O
-    O
halogenated    O
19-nortestosterone    O
derivatives    O
norgestrel    O
,    O
norethisterone    B-Acetylene114600742
,    O
noretynodrel    O
,    O
and    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
were    O
not    O
found    O
to    O
produce    O
such    O
nodules    O
.    O

It    O
is    O
a    O
chloroethynylated    O
derivative    O
of    O
norethisterone    B-Acetylene114600742
.    O

In    O
contrast    O
,    O
the    O
non    O
-    O
halogenated    O
19-nortestosterone    O
derivatives    O
norgestrel    O
,    O
norethisterone    B-Acetylene114600742
,    O
noretynodrel    O
,    O
and    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
which    O
are    O
much    O
less    O
potent    O
as    O
progestogens    O
,    O
did    O
not    O
produce    O
such    O
effects    O
at    O
the    O
dosages    O
tested    O
.    O

Norsteroid    O
examples    O
include    O
:    O
19-norpregnane    O
(    O
from    O
pregnane    O
)    O
,    O
desogestrel    B-Acetylene114600742
,    O
ethylestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
ethinylestradiol    O
,    O
gestrinone    B-Acetylene114600742
,    O
levonorgestrel    B-Acetylene114600742
,    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norgestrel    O
,    O
norpregnatriene    O
(    O
from    O
pregnatriene    O
)    O
,    O
quinestrol    O
,    O
19-norprogesterone    O
(    O
from    O
a    O
progesterone    O
)    O
,    O
Nomegestrol    O
acetate    O
,    O
19-nortestosterone    O
(    O
from    O
a    O
testosterone    O
)    O
,    O
and    O
norethisterone    O
acetate    O
.    O

Nandrolone    O
,    O
together    O
with    O
ethisterone    O
(    O
17α-ethynyltestosterone    O
)    O
,    O
is    O
also    O
the    O
parent    O
compound    O
of    O
a    O
large    O
group    O
of    O
progestins    O
,    O
the    O
norethisterone    B-Acetylene114600742
(    O
17α-ethynyl-19-nortestosterone    O
)    O
derivatives    O
.    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

In    O
1978    O
the    O
company    O
brought    O
to    O
market    O
the    O
first    O
once    O
-    O
a    O
-    O
week    O
oral    O
contraceptive    O
"    O
Deposiston    O
"    O
,    O
a    O
combination    O
of    O
ethinylestradiol    O
sulfonate    O
and    O
norethisterone    B-Acetylene114600742
acetate    O
.    O

Treatment    O
with    O
a    O
progestin    O
,    O
norethisterone    B-Acetylene114600742
,    O
reduced    O
her    O
estradiol    O
concentrations    O
to    O
normal    O
levels    O
and    O
decreased    O
the    O
size    O
of    O
her    O
ovaries    O
and    O
the    O
number    O
of    O
ovarian    O
cysts    O
,    O
alleviating    O
her    O
hypothalamic    O
-    O
pituitary    O
-    O
gonadal    O
axis    O
hyperactivity    O
and    O
ovarian    O
pathology    O
.    O

Examples    O
include    O
drugs    O
such    O
as    O
Norethisterone    B-Acetylene114600742
,    O
Ethisterone    O
,    O
and    O
Lynestrenol    O
.    O

A    O
2001    O
comparative    O
study    O
of    O
the    O
IMS    O
LifeLink    O
Health    O
Plan    O
Claims    O
Database    O
interpreted    O
that    O
in    O
a    O
large    O
cohort    O
of    O
women    O
using    O
oral    O
contraceptives    O
,    O
there    O
was    O
found    O
a    O
small    O
,    O
statistically    O
significant    O
increase    O
in    O
the    O
risk    O
of    O
gallbladder    O
disease    O
associated    O
with    O
desogestrel    B-Acetylene114600742
,    O
drospirenone    O
and    O
norethisterone    B-Acetylene114600742
compared    O
with    O
levonorgestrel    B-Acetylene114600742
.    O

Conversely    O
,    O
replacement    O
of    O
the    O
C17α    O
alkyl    O
group    O
with    O
an    O
ethynyl    O
group    O
greatly    O
reduces    O
but    O
does    O
not    O
abolish    O
androgenic    O
activity    O
,    O
as    O
in    O
ethisterone    O
(    O
17α-ethynyltestosterone    O
)    O
and    O
norethisterone    B-Acetylene114600742
(    O
17α-ethynyl-19-nortestosterone    O
)    O
.    O

Camila    O
,    O
brand    O
name    O
of    O
a    O
progestogen    O
-    O
only    O
pill    O
containing    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O

Gestodene    B-Acetylene114600742
is    O
a    O
19-nortestosterone    O
derivative    O
with    O
antimineralocorticoid    O
properties    O
.    O

gestodene    B-Acetylene114600742
(    O
INN    O
)    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

Ynol    B-Acetylene114600742

An    O
enyne    B-Acetylene114600742
is    O
a    O
functional    O
group    O
in    O
organic    O
chemistry    O
consisting    O
of    O
a    O
conjugated    O
alkyne    O
and    O
alkene    O
group    O
.    O

One    O
such    O
pharmaceutical    O
application    O
is    O
in    O
the    O
synthesis    O
of    O
SIB-1508Y    O
,    O
which    O
is    O
more    O
commonly    O
known    O
as    O
Altinicline    B-Acetylene114600742
.    O

oxotremorine    B-Acetylene114600742

to    O
mice    O
,    O
DMDA    O
failed    O
to    O
antagonize    O
the    O
tremor    O
and    O
reduction    O
in    O
locomotor    O
activity    O
produced    O
by    O
pre    O
-    O
administration    O
of    O
oxotremorine    B-Acetylene114600742
.    O

Squarate    O
and    O
related    O
anions    O
such    O
deltate    O
and    O
acetylenediolate    B-Acetylene114600742
have    O
been    O
obtained    O
from    O
carbon    O
monoxide    O
under    O
mild    O
conditions    O
by    O
reductive    O
coupling    O
of    O
CO    O
ligands    O
in    O
organouranium    O
complexes    O
.    O

Acetylenediol    B-Acetylene114600742

Drugs    O
:    O
diuretics    O
(    O
e.g.    O
,    O
thiazides    O
,    O
furosemide    O
)    O
,    O
gliptins    O
(    O
e.g.    O
,    O
vildagliptin    O
,    O
sitagliptin    O
,    O
saxagliptin    O
,    O
linagliptin    B-Acetylene114600742
)    O
,    O
tetracycline    O
,    O
sulfonamides    O
,    O
estrogens    O
,    O
azathioprine    O
and    O
mercaptopurine    O
,    O
pentamidine    O
,    O
salicylates    O
,    O
steroids    O
,    O
Depakote    O

linagliptin    B-Acetylene114600742
(    O
INN    O
)    O

Acetylene    O
is    O
the    O
third    O
-    O
hottest    O
natural    O
chemical    O
flame    O
after    O
dicyanoacetylene    B-Acetylene114600742
's    O
and    O
cyanogen    O
at    O
.    O

A    O
MAO    O
-    O
B    O
inhibitor    O
such    O
as    O
selegiline    O
or    O
rasagiline    B-Acetylene114600742
can    O
prevent    O
this    O
from    O
happening    O
.    O

Moussa    O
B.H.    O
Youdim    O
developed    O
Rasagiline    B-Acetylene114600742
,    O
a    O
drug    O
marketed    O
by    O
Teva    O
Pharmaceuticals    O
as    O
Azilect    B-Acetylene114600742
(TM)    I-Acetylene114600742
for    O
the    O
treatment    O
of    O
neurodegenerative    O
disease    O
,    O
especially    O
Parkinsons    O
.    O

MAO    O
-    O
B    O
inhibitors    O
(    O
safinamide    O
,    O
selegiline    O
and    O
rasagiline    B-Acetylene114600742
)    O
increase    O
the    O
amount    O
of    O
dopamine    O
in    O
the    O
basal    O
ganglia    O
by    O
inhibiting    O
the    O
activity    O
of    O
monoamine    O
oxidase    O
B    O
(    O
MAO    O
-    O
B    O
)    O
,    O
an    O
enzyme    O
which    O
breaks    O
down    O
dopamine    O
.    O

Agents    O
currently    O
under    O
investigation    O
include    O
anti    O
-    O
apoptotics    O
(    O
omigapil    O
,    O
CEP-1347    O
)    O
,    O
antiglutamatergics    O
,    O
monoamine    O
oxidase    O
inhibitors    O
(    O
selegiline    O
,    O
rasagiline    B-Acetylene114600742
)    O
,    O
promitochondrials    O
(    O
coenzyme    O
Q10    O
,    O
creatine    O
)    O
,    O
calcium    O
channel    O
blockers    O
(    O
isradipine    O
)    O
and    O
growth    O
factors    O
(    O
GDNF    O
)    O
.    O

Tariric    B-Acetylene114600742
acid    I-Acetylene114600742
is    O
an    O
acetylenic    O
fatty    O
acid    O
that    O
can    O
be    O
found    O
in    O
the    O
tallow    O
-    O
wood    O
tree    O
,    O
"    O
Ximenia    O
americana    O
"    O
.    O

Sazetidine    B-Acetylene114600742
A    I-Acetylene114600742
(    O
AMOP-H-OH    B-Acetylene114600742
)    O
is    O
a    O
drug    O
which    O
acts    O
as    O
a    O
subtype    O
selective    O
partial    O
agonist    O
at    O
α4β2    O
neural    O
nicotinic    O
acetylcholine    O
receptors    O
,    O
acting    O
as    O
an    O
agonist    O
at    O
(    O
α4)2(β2)3    O
pentamers    O
,    O
but    O
as    O
an    O
antagonist    O
at    O
(    O
α4)3(β2)2    O
pentamers    O
.    O

Panaxytriol    B-Acetylene114600742
is    O
a    O
fatty    O
alcohol    O
found    O
in    O
ginseng    O
.    O

1-Decyne    B-Acetylene114600742
is    O
an    O
alkyne    O
hydrocarbon    O
with    O
the    O
chemical    O
formula    O
C10H18    O
.    O

It    O
is    O
first    O
in    O
the    O
series    O
of    O
polyyne    B-Acetylene114600742
,    O
which    O
are    O
of    O
theoretical    O
but    O
not    O
of    O
practical    O
interest    O
.    O

Compounds    O
called    O
polyacetylenes    O
also    O
occur    O
in    O
nature    O
,    O
although    O
in    O
this    O
context    O
the    O
term    O
refers    O
to    O
polyyne    B-Acetylene114600742
,    O
compounds    O
containing    O
multiple    O
acetylene    O
groups    O
(    O
"    O
poly    O
"    O
meaning    O
"    O
many    O
"    O
)    O
,    O
rather    O
than    O
to    O
chains    O
of    O
olefin    O
groups    O
(    O
"    O
poly    O
"    O
meaning    O
"    O
polymerization    O
of    O
"    O
)    O
.    O

Tannin    O
,    O
for    O
example    O
,    O
is    O
a    O
defensive    O
compound    O
that    O
emerged    O
relatively    O
early    O
in    O
the    O
evolutionary    O
history    O
of    O
plants    O
,    O
while    O
more    O
complex    O
molecules    O
such    O
as    O
polyacetylenes    B-Acetylene114600742
are    O
found    O
in    O
younger    O
groups    O
of    O
plants    O
such    O
as    O
the    O
Asterales    O
.    O

In    O
organic    O
chemistry    O
,    O
the    O
hexadehydro    O
-    O
Diels    O
-    O
Alder    O
(    O
HDDA    O
)    O
reaction    O
is    O
an    O
organic    O
chemical    O
reaction    O
between    O
a    O
diyne    B-Acetylene114600742
(    O
2    O
alkyne    O
functional    O
groups    O
arranged    O
in    O
a    O
conjugated    O
system    O
)    O
and    O
an    O
alkyne    O
to    O
form    O
a    O
reactive    O
benzyne    O
species    O
,    O
via    O
a    O
[    O
4    O
+    O
2    O
]    O
cycloaddition    O
reaction    O
.    O

Polyyne    B-Acetylene114600742

The    O
calicheamicins    B-Acetylene114600742
are    O
a    O
class    O
of    O
enediyne    B-Acetylene114600742
antitumor    O
antibiotics    O
derived    O
from    O
the    O
bacterium    O
"    O
Micromonospora    O
echinospora    O
"    O
,    O
with    O
calicheamicin    O
γ1    O
being    O
the    O
most    O
notable    O
.    O

The    O
core    O
metabolic    O
pathway    O
for    O
biosynthesis    O
of    O
this    O
molecule    O
resembles    O
that    O
of    O
other    O
characterized    O
enediyne    B-Acetylene114600742
compounds    O
and    O
occurs    O
via    O
an    O
iterative    O
polyketide    O
synthase    O
(    O
PKS    O
)    O
pathway    O
.    O

Enediyne    B-Acetylene114600742

Trimethylsilyl    O
chloride    O
also    O
reacts    O
with    O
metal    O
acetylides    O
to    O
give    O
trimethylsilyl    O
alkynes    O
such    O
as    O
bis(trimethylsilyl)acetylene    B-Acetylene114600742
.    O

Phenylpropiolic    B-Acetylene114600742
acid    I-Acetylene114600742

Ethynol    B-Acetylene114600742

Butinoline    B-Acetylene114600742

AMG-1    B-Acetylene114600742
(    O
part    O
of    O
the    O
AM    O
cannabinoid    O
series    O
)    O
is    O
an    O
analgesic    O
drug    O
which    O
is    O
a    O
cannabinoid    O
agonist    O
.    O

ladostigil    B-Acetylene114600742
(    O
INN    O
)    O

Intriptyline    B-Acetylene114600742

Norsteroid    O
examples    O
include    O
:    O
19-norpregnane    O
(    O
from    O
pregnane    O
)    O
,    O
desogestrel    B-Acetylene114600742
,    O
ethylestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
ethinylestradiol    O
,    O
gestrinone    B-Acetylene114600742
,    O
levonorgestrel    B-Acetylene114600742
,    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norgestrel    O
,    O
norpregnatriene    O
(    O
from    O
pregnatriene    O
)    O
,    O
quinestrol    O
,    O
19-norprogesterone    O
(    O
from    O
a    O
progesterone    O
)    O
,    O
Nomegestrol    O
acetate    O
,    O
19-nortestosterone    O
(    O
from    O
a    O
testosterone    O
)    O
,    O
and    O
norethisterone    O
acetate    O
.    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

No    O
statistically    O
significant    O
increase    O
in    O
risk    O
was    O
associated    O
with    O
the    O
other    O
formulations    O
of    O
oral    O
contraceptive    O
(    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
norgestrel    O
and    O
norgestimate    B-Acetylene114600742
)    O
.    O

Methylpentynol    B-Acetylene114600742
(    O
INN    O
)    O

Folotyn    O
(    O
pralatrexate    B-Acetylene114600742
)    O
is    O
an    O
antifolate    O
drug    O
marketed    O
for    O
relapsed    O
or    O
refractory    O
peripheral    O
T    O
-    O
cell    O
lymphoma    O
.    O

Pralatrexate    B-Acetylene114600742
is    O
one    O
compound    O
currently    O
under    O
investigations    O
for    O
the    O
treatment    O
of    O
PTCL    O
.    O

Drugs    O
such    O
as    O
panitumumab    O
,    O
cetuximab    O
,    O
gefitinib    O
,    O
erlotinib    B-Acetylene114600742
,    O
afatinib    O
,    O
and    O
lapatinib    O
are    O
used    O
to    O
inhibit    O
it    O
.    O

2004    O
–    O
Tarceva    B-Acetylene114600742
(    O
erlotinib    O
)    O
:    O
Treatment    O
for    O
patients    O
with    O
locally    O
advanced    O
or    O
metastatic    O
non    O
-    O
small    O
cell    O
lung    O
cancer    O
,    O
and    O
pancreatic    O
cancer    O
.    O

However    O
,    O
the    O
combination    O
of    O
gemcitabine    O
with    O
erlotinib    B-Acetylene114600742
was    O
found    O
to    O
increase    O
survival    O
modestly    O
,    O
and    O
erlotinib    O
was    O
licensed    O
by    O
the    O
FDA    O
for    O
use    O
in    O
pancreatic    O
cancer    O
in    O
2005    O
.    O

The    O
JUNIPER    O
Study    O
is    O
comparing    O
Abemaciclib    O
against    O
Erlotinib    B-Acetylene114600742
in    O
patients    O
with    O
stage    O
IV    O
Non    O
-    O
small    O
-    O
cell    O
lung    O
carcinoma    O

Gefitinib    O
is    O
an    O
EGFR    O
inhibitor    O
,    O
like    O
erlotinib    B-Acetylene114600742
,    O
which    O
interrupts    O
signaling    O
through    O
the    O
epidermal    O
growth    O
factor    O
receptor    O
(    O
EGFR    O
)    O
in    O
target    O
cells    O
.    O

Genzyme    O
,    O
QIAGEN    O
,    O
Argenomics    O
S.A.    O
&    O
other    O
companies    O
make    O
tests    O
to    O
detect    O
"    O
EGFR    O
"    O
mutations    O
,    O
designed    O
to    O
help    O
predict    O
which    O
lung    O
cancer    O
patients    O
may    O
respond    O
best    O
to    O
some    O
therapies    O
,    O
including    O
gefitinib    O
and    O
erlotinib    B-Acetylene114600742
.    O

Erlotinib    B-Acetylene114600742
,    O
another    O
EGFR    O
tyrosine    O
kinase    O
inhibitor    O
that    O
has    O
a    O
similar    O
mechanism    O
of    O
action    O
to    O
gefitinib    O
.    O

2C-YN    B-Acetylene114600742
,    O
an    O
analogue    O
of    O
the    O
phenethylamine    O
derived    O
hallucinogen    O
2C    O
-    O
E    O

Polydiacetylenes    B-Acetylene114600742
(    O
PDAs    B-Acetylene114600742
)    O
are    O
a    O
family    O
of    O
conducting    O
polymers    O
closely    O
related    O
to    O
polyacetylene    O
.    O

Future    O
attacks    O
of    O
hereditary    O
angioedema    O
can    O
be    O
prevented    O
by    O
the    O
use    O
of    O
androgens    O
such    O
as    O
danazol    B-Acetylene114600742
,    O
oxandrolone    O
or    O
methyltestosterone    O
.    O

Danazol    B-Acetylene114600742
may    O
also    O
be    O
prescribed    O
to    O
treat    O
this    O
condition    O
and    O
it    O
is    O
usually    O
considered    O
in    O
patients    O
on    O
whom    O
the    O
non    O
-    O
medical    O
treatment    O
fails    O
and    O
the    O
symptoms    O
are    O
intense    O
.    O

Steroid    O
sulfatase    O
(    O
STS    O
)    O
inhibitors    O
such    O
as    O
estradiol    O
sulfamate    O
,    O
estrone    O
sulfamate    O
,    O
irosustat    O
,    O
and    O
danazol    B-Acetylene114600742
inhibit    O
the    O
conversion    O
of    O
steroid    O
sulfates    O
such    O
as    O
estrone    O
sulfate    O
and    O
DHEA    O
sulfate    O
into    O
their    O
hormonally    O
active    O
forms    O
.    O

Danazol    B-Acetylene114600742
is    O
a    O
steroid    O
compound    O
that    O
has    O
been    O
labelled    O
as    O
an    O
"    O
Anterior    O
pituitary    O
suppressant    O
"    O
.    O

This    O
can    O
also    O
be    O
accomplished    O
with    O
progestational    O
agents    O
(    O
i.e.    O
,    O
medroxyprogesterone    O
acetate    O
)    O
,    O
danazol    B-Acetylene114600742
,    O
gestrinone    B-Acetylene114600742
,    O
or    O
gonadotropin    O
-    O
releasing    O
hormone    O
agonists    O
(    O
GnRH    O
)    O
,    O
as    O
well    O
as    O
other    O
less    O
well    O
-    O
known    O
agents    O
.    O

Treatment(s    O
)    O
with    O
mixed    O
success    O
:    O
omalizumab    O
(    O
anti    O
-    O
IgE    O
therapy    O
)    O
,    O
danazol    B-Acetylene114600742
(    O
synthetic    O
androgen    O
)    O
,    O
propranolol    O
(    O
beta    O
blocker    O
)    O
,    O
zileuton    O
(    O
antileukotriene    O
)    O
.    O

The    O
hexatriynyl    B-Acetylene114600742
radical    I-Acetylene114600742
,    O
C6H    O
,    O
is    O
an    O
organic    O
radical    O
molecule    O
consisting    O
of    O
a    O
chain    O
of    O
six    O
carbon    O
atoms    O
terminated    O
by    O
a    O
hydrogen    O
.    O

#    O
Ethinamate    B-Acetylene114600742

ethinamate    B-Acetylene114600742

Aliphatic    O
compounds    O
can    O
be    O
saturated    O
,    O
like    O
hexane    O
,    O
or    O
unsaturated    O
,    O
like    O
hexene    O
and    O
hexyne    B-Acetylene114600742
.    O

1-Pentyne    B-Acetylene114600742
,    O
an    O
organic    O
compound    O
,    O
is    O
a    O
terminal    O
alkyne    O
.    O

5-Ethynyl-2´-deoxyuridine    B-Acetylene114600742
(    O
EdU    O
)    O
is    O
a    O
thymidine    O
analog    O
which    O
is    O
incorporated    O
into    O
the    O
DNA    O
of    O
dividing    O
cells    O
and    O
is    O
used    O
to    O
assay    O
DNA    O
synthesis    O
in    O
cell    O
culture    O
or    O
living    O
tissues    O
.    O

:    O
1,4-Butynediol    B-Acetylene114600742
is    O
produced    O
industrially    O
in    O
this    O
way    O
from    O
formaldehyde    O
and    O
acetylene    O
.    O

SB-205,384    B-Acetylene114600742

For    O
example    O
,    O
reaction    O
with    O
benzyne    O
leads    O
to    O
1,2,3,4-tetraphenylnaphthalene    O
and    O
reaction    O
with    O
diphenylacetylene    B-Acetylene114600742
leads    O
to    O
hexaphenylbenzene    O
.    O

Together    O
with    O
2-butyne    B-Acetylene114600742
and    O
diphenylacetylene    B-Acetylene114600742
,    O
it    O
serves    O
as    O
a    O
reference    O
acetylenic    O
ligand    O
in    O
organometallic    O
chemistry    O
.    O

It    O
may    O
be    O
prepared    O
through    O
a    O
Diels    O
-    O
Alder    O
reaction    O
by    O
refluxing    O
tetraphenylcyclopentadienone    O
and    O
diphenylacetylene    B-Acetylene114600742
in    O
benzophenone    O
or    O
other    O
high    O
-    O
temperature    O
solvent    O
.    O

Transannular    O
strain    O
can    O
also    O
be    O
demonstrated    O
in    O
other    O
cyclo    O
-    O
organic    O
molecules    O
,    O
such    O
as    O
lactones    O
,    O
lactams    O
,    O
ethers    O
,    O
cycloalkenes    O
,    O
and    O
cycloalkyne    B-Acetylene114600742
.    O

gestrinone    B-Acetylene114600742
(    O
INN    O
)    O

Norsteroid    O
examples    O
include    O
:    O
19-norpregnane    O
(    O
from    O
pregnane    O
)    O
,    O
desogestrel    B-Acetylene114600742
,    O
ethylestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
ethinylestradiol    O
,    O
gestrinone    B-Acetylene114600742
,    O
levonorgestrel    B-Acetylene114600742
,    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norgestrel    O
,    O
norpregnatriene    O
(    O
from    O
pregnatriene    O
)    O
,    O
quinestrol    O
,    O
19-norprogesterone    O
(    O
from    O
a    O
progesterone    O
)    O
,    O
Nomegestrol    O
acetate    O
,    O
19-nortestosterone    O
(    O
from    O
a    O
testosterone    O
)    O
,    O
and    O
norethisterone    O
acetate    O
.    O

This    O
can    O
also    O
be    O
accomplished    O
with    O
progestational    O
agents    O
(    O
i.e.    O
,    O
medroxyprogesterone    O
acetate    O
)    O
,    O
danazol    B-Acetylene114600742
,    O
gestrinone    B-Acetylene114600742
,    O
or    O
gonadotropin    O
-    O
releasing    O
hormone    O
agonists    O
(    O
GnRH    O
)    O
,    O
as    O
well    O
as    O
other    O
less    O
well    O
-    O
known    O
agents    O
.    O

butynamine    B-Acetylene114600742
(    O
INN    O
)    O

An    O
example    O
is    O
the    O
coupling    O
of    O
trimethylsilylacetylene    B-Acetylene114600742
.    O

2-Butyne    B-Acetylene114600742
(    O
dimethylacetylene    O
)    O

Later    O
,    O
a    O
more    O
stable    O
2-butyne    B-Acetylene114600742
linkage    O
was    O
selected    O
.    O

Falcarindiol    B-Acetylene114600742
which    O
activates    O
the    O
nuclear    O
receptor    O
PPARgamma    O
,    O
and    O
induces    O
expression    O
of    O
antioxidant    O
enzymes    O
"    O
in    O
vitro    O
"    O
.    O

Methohexital    B-Acetylene114600742
(    O
trade    O
name    O
:    O
Brevital    O
)    O

Methohexital    B-Acetylene114600742

MTEP    B-Acetylene114600742
:    O
more    O
potent    O
than    O
MPEP    O

Tibolone    B-Acetylene114600742

Tibolone    B-Acetylene114600742

Tibolone    B-Acetylene114600742

Mavoglurant    B-Acetylene114600742

Diacetylene    B-Acetylene114600742
(    O
also    O
known    O
as    O
butadiyne    B-Acetylene114600742
)    O
is    O
the    O
organic    O
compound    O
with    O
the    O
formula    O
C4H2    O
.    O

The    O
simplest    O
model    O
of    O
an    O
HDDA    O
reaction    O
is    O
the    O
cycloaddition    O
of    O
butadiyne    B-Acetylene114600742
and    O
acetylene    O
to    O
form    O
ortho    O
-    O
benzyne    O
(    O
o    O
-    O
benzyne    O
,    O
shown    O
below    O
)    O
.    O

The    O
cage    O
is    O
fireproof    O
and    O
is    O
capable    O
of    O
spraying    O
diacetylene    B-Acetylene114600742
out    O
of    O
side    O
and    O
base    O
panels    O
in    O
case    O
of    O
the    O
shaft    O
being    O
on    O
fire    O
.    O

Decyne    B-Acetylene114600742

5,12-Bis(phenylethynyl)naphthacene    B-Acetylene114600742
is    O
a    O
fluorescent    O
dye    O
used    O
in    O
lightsticks    O
.    O

A    O
variety    O
of    O
commercially    O
available    O
systemic    O
and    O
non    O
-    O
systemic    O
miticides    O
:    O
abamectin    O
,    O
acequinocyl    O
,    O
bifenazate    O
,    O
bifenazate    O
,    O
chlorfenapyr    O
,    O
clofentezine    O
,    O
cyflumetofen    O
,    O
cypermethrin    O
,    O
dicofol    O
,    O
etoxazole    O
,    O
fenazaquin    O
,    O
fenpyroximate    O
,    O
hexythiazox    O
,    O
imidacloprid    O
,    O
propargite    B-Acetylene114600742
,    O
pyridaben    O
,    O
spiromesifen    O
,    O
spirotetramat    O
.    O

Ring    O
A    O
synthesis    O
(    O
"    O
scheme    O
1    O
"    O
)    O
started    O
by    O
joining    O
the    O
THP    O
protected    O
propargyl    B-Acetylene114600742
alcohol    I-Acetylene114600742
1.1    O
(    O
the    O
C2-C1-C14    O
fragment    O
)    O
and    O
propionaldehyde    O
1.2    O
(    O
fragment    O
C13-C12-C18    O
)    O
in    O
a    O
nucleophilic    O
addition    O
with    O
"    O
n    O
"-    O
butyllithium    O
to    O
alcohol    O
1.3    O
.    O

Propargyl    O
bromide    O
may    O
be    O
produced    O
by    O
the    O
treatment    O
of    O
propargyl    B-Acetylene114600742
alcohol    I-Acetylene114600742
with    O
phosphorus    O
tribromide    O
.    O

Propargyl    B-Acetylene114600742
alcohol    I-Acetylene114600742

The    O
methylphenyl    O
group    O
occupies    O
a    O
hydrophobic    O
pocket    O
behind    O
I315    O
,    O
the    O
ethynyl    B-Acetylene114600742
linkage    O
forms    O
favorable    O
van    O
der    O
Waals    O
interactions    O
with    O
the    O
amino    O
acid    O
and    O
the    O
trifluoromethyl    O
group    O
binds    O
to    O
a    O
pocket    O
induced    O
by    O
the    O
inactive    O
conformation    O
kinase    O
.    O

Carbo-mer    B-Acetylene114600742
,    O
an    O
expanded    O
molecule    O
obtained    O
by    O
insertion    O
of    O
a    O
C2    O
unit    O
in    O
a    O
given    O
molecule    O

The    O
most    O
potent    O
of    O
these    O
receptor    O
agonists    O
for    O
binding    O
to    O
and    O
activating    O
IP    O
are    O
iloprost    B-Acetylene114600742
,    O
taprostene    O
,    O
and    O
esuberaprost    O
which    O
have    O
Kd    O
values    O
(    O
i.e.    O
concentrations    O
which    O
bind    O
to    O
half    O
of    O
available    O
IP    O
receptors    O
)    O
in    O
the    O
low    O
nanamole    O
/    O
liter    O
range    O
(    O
http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345/    O
)    O
.    O

Major    O
drugs    O
in    O
this    O
category    O
include    O
PGI2    O
itself    O
(    O
i.e.    O
epoprostenol    O
)    O
,    O
iloprost    B-Acetylene114600742
,    O
treprostinil    O
,    O
and    O
beraprost    B-Acetylene114600742
with    O
epoprostenol    O
being    O
favored    O
in    O
some    O
studies    O
.    O

Iloprost    B-Acetylene114600742
(    O
Prostacyclin    O
)    O

Difluoroacetylene    B-Acetylene114600742
,    O
which    O
decomposes    O
even    O
under    O
liquid    O
nitrogen    O
temperatures    O
,    O
is    O
a    O
notable    O
example    O
.    O

Halotex    B-Acetylene114600742

2-Chloro-9,10-bis(phenylethynyl)anthracene    B-Acetylene114600742

etonogestrel    B-Acetylene114600742
(    O
INN    O
)    O

The    O
estranes    O
include    O
norethisterone    B-Acetylene114600742
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    B-Acetylene114600742
diacetate    I-Acetylene114600742
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    B-Acetylene114600742
,    O
desogestrel    B-Acetylene114600742
,    O
etonogestrel    B-Acetylene114600742
,    O
gestodene    B-Acetylene114600742
,    O
norgestimate    B-Acetylene114600742
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    B-Acetylene114600742
.    O

An    O
example    O
is    O
provided    O
by    O
cyanodiacetylene    B-Acetylene114600742
,    O
H−C≡C−C≡C−C≡N.    O

The    O
two    O
species    O
C4H−    O
and    O
C8H    B-Acetylene114600742
have    O
also    O
been    O
detected    O
.    O

Annulynes    B-Acetylene114600742
or    O
1,2-didehydroannulenes    B-Acetylene114600742
are    O
conjugated    O
monocyclic    O
hydrocarbons    O
with    O
alternating    O
alkene    O
bonds    O
in    O
addition    O
to    O
at    O
least    O
one    O
alkyne    O
bond    O
.    O

CAR-302,196    B-Acetylene114600742

The    O
SSRI    O
fluoxetine    O
and    O
the    O
MAO    O
-    O
A    O
inhibitor    O
clorgyline    B-Acetylene114600742
upregulate    O
AANAT    O
indirectly    O
through    O
serotonergic    O
mechanisms    O
and    O
thereby    O
increase    O
NAS    O
levels    O
after    O
chronic    O
administration    O
,    O
and    O
this    O
correlates    O
with    O
the    O
onset    O
of    O
their    O
antidepressant    O
effects    O
.    O

It    O
reduces    O
blood    O
pressure    O
in    O
rodents    O
,    O
and    O
pinealectomy    O
(    O
the    O
pineal    O
gland    O
being    O
a    O
major    O
site    O
of    O
NAS    O
and    O
melatonin    O
synthesis    O
)    O
abolishes    O
the    O
hypotensive    O
effects    O
of    O
clorgyline    B-Acetylene114600742
.    O

A-41988    B-Acetylene114600742
(    O
BW29Y    B-Acetylene114600742
)    O
is    O
an    O
analgesic    O
drug    O
which    O
acts    O
as    O
a    O
cannabinoid    O
agonist    O
.    O

Specific    O
examples    O
include    O
its    O
use    O
in    O
the    O
synthesis    O
of    O
tazarotene    B-Acetylene114600742
,    O
which    O
is    O
a    O
treatment    O
for    O
psoriasis    O
and    O
acne    O
,    O
and    O
in    O
the    O
preparation    O
of    O
SIB-1508Y    O
,    O
also    O
known    O
as    O
Altinicline    B-Acetylene114600742
,    O
which    O
is    O
a    O
potential    O
treatment    O
for    O
Parkinson    O
's    O
disease    O
,    O
Alzheimer    O
's    O
disease    O
,    O
Tourette    O
syndrome    O
,    O
schizophrenia    O
,    O
and    O
attention    O
deficit    O
hyperactivity    O
disorder    O
(    O
ADHD    O
)    O
.    O


